Revenio Group Oyj — Director's Dealing 2022

Feb 17, 2022

Revenio Group Corporation: Managers' Transactions – Pulkkinen Robin

Revenio Group Corporation: Managers' Transactions – Pulkkinen Robin

Revenio Group Corporation, Managers’ transactions, February 17, 2022 at 4.30 p.m. (EET)

Revenio Group Corporation: Managers' Transactions – Pulkkinen Robin

Person subject to the notification requirement

Name: Robin Pulkkinen

Position: Chief Financial Officer

Issuer: Revenio Group Oyj

LEI: 743700I27E0FWSXLKK04

Notification type: INITIAL NOTIFICATION

Reference number: 10140/5/4

Transaction date: 2022-02-14

Venue: NASDAQ HELSINKI LTD (XHEL)

Instrument type: SHARE

ISIN: FI0009010912

Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details

(1): Volume: 2019 Unit price:

Aggregated transactions

(1): Volume: 2019 Volume weighted average price:

For further information, please contact:

CFO Robin Pulkkinen, tel. +358 50 505 9932

robin.pulkkinen@revenio.fi

www.revenio.fi

DISTRIBUTION:

Nasdaq Helsinki Ltd

Main media

www.revenio.fi

Revenio Group in brief

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. In addition, the Group’s eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring and data analytics capabilities.

In 2021, the Group’s net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments: